Concourse Financial Group Securities’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Concourse Financial Group Securities’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15	Closed	-$612	–	2324
2023 Q3	$589	Hold	15	–	–	﹤0.01%	2160
2023 Q2	$702	Hold	15	–	–	﹤0.01%	2184
2023 Q1	$714	Hold	15	–	–	﹤0.01%	2211
2022 Q4	$733	Sell	15 -441	-97%	-$22.7K	﹤0.01%	2208
2022 Q3	$23K	Sell	456 -42	-8%	-$2.37K	﹤0.01%	1254
2022 Q2	$24K	Sell	498 -25	-5%	-$1.27K	﹤0.01%	1388
2022 Q1	$31K	Sell	523 -1,999	-79%	-$126K	﹤0.01%	1324
2021 Q4	$200K	Buy	2,522 +178	+8%	+$15K	0.01%	726
2021 Q3	$208K	Buy	2,344 +7	+0.3%	+$656	0.01%	708
2021 Q2	$233K	Buy	2,337 +21	+0.9%	+$1.86K	0.01%	664
2021 Q1	$208K	Sell	2,316 -637	-22%	-$62.9K	0.01%	670
2020 Q4	$279K	Sell	2,953 -410	-12%	-$34.3K	0.02%	519
2020 Q3	$242K	Buy	+3,363	New	+$241K	0.02%	494

Other funds holding GNOM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

SWA

Sightline Wealth Advisors Groton, Connecticut $236M AUM 12.89% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Concourse Financial Group Securities's GNOM Position: Q4 2023 in Review

Concourse Financial Group Securities sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2023, closing a stake of 15 shares — an estimated $612 sold.

Concourse Financial Group Securities first reported a position in GNOM in Q3 2020 and held it in 13 quarters. The position peaked at $279K in Q4 2020. 61 funds tracked by Wall St. Rank hold GNOM as of Q4 2023.

Concourse Financial Group Securities reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
Concourse Financial Group Securities sold 15 Global X Genomics & Biotechnology ETF shares in Q4 2023, an estimated $612.
Concourse Financial Group Securities first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and held it in 13 quarters.
Concourse Financial Group Securities's Global X Genomics & Biotechnology ETF position peaked at $279K in Q4 2020.
61 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2023.

Based on Concourse Financial Group Securities's 13F filing for Q4 2023, filed 7 Feb 2024.